ALEXIS, A. F.; YAMAUCHI, P. S.; LIN, T.; MARTIN, G. Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S28, 2019. DOI: 10.25251/skin.3.supp.28. Disponível em: https://jofskin.org/index.php/skin/article/view/755. Acesso em: 22 jul. 2024.